Cargando…

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy

We compared the impact of treatment strategies on postoperative complications and prognosis between robot-assisted radical prostatectomy (RARP) plus extended pelvic lymph-node dissection (ePLND) and RARP plus neoadjuvant chemohormonal therapy (NCHT) without ePLND. We retrospectively evaluated 452 pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oishi, Takuya, Hatakeyama, Shingo, Tabata, Ryuji, Fujimori, Daiji, Fukuda, Mamoru, Shinozaki, Tetsuo, Ishii, Noritaka, Iwamura, Hiromichi, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Sato, Satoshi, Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978020/ https://www.ncbi.nlm.nih.gov/pubmed/36859718 http://dx.doi.org/10.1038/s41598-023-30627-7

Ejemplares similares

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids
por: Ishii, Noritaka, et al.
Publicado: (2022)

Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study)
por: Momota, Masaki, et al.
Publicado: (2020)

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study
por: Iwamura, Hiromichi, et al.
Publicado: (2015)

Relationship of frailty with treatment modality selection in patients with muscle-invasive bladder cancer (FRART-BC study)
por: Iwamura, Hiromichi, et al.
Publicado: (2021)

Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma
por: Iwamura, Hiromichi, et al.
Publicado: (2018)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study
por: Hagiwara, Kazuhisa, et al.
Publicado: (2016)

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy
por: Hosogoe, Shogo, et al.
Publicado: (2015)

Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma
por: Momota, Masaki, et al.
Publicado: (2018)

Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer
por: Babst, Christa, et al.
Publicado: (2022)

Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study
por: Ozaki, Yusuke, et al.
Publicado: (2023)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy
por: Iwamura, Hiromichi, et al.
Publicado: (2014)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity
por: OKAMOTO, TEPPEI, et al.
Publicado: (2013)

Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
por: Fujita, Naoki, et al.
Publicado: (2023)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
por: Sasaki, Takeshi, et al.
Publicado: (2021)

Neoadjuvant Chemohormonal Therapy in Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
por: Ge, Qingyu, et al.
Publicado: (2022)

Clinical efficacy of neoadjuvant chemohormonal therapy combined with laparoscopic radical prostatectomy in high-risk Prostate Cancer
por: Zhang, Peng, et al.
Publicado: (2022)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
por: Koie, Takuya, et al.
Publicado: (2013)

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
por: Konishi, Sakae, et al.
Publicado: (2021)

Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
por: Anan, Go, et al.
Publicado: (2017)

Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer
por: Kubota, Yuka, et al.
Publicado: (2019)

Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease
por: Hatakeyama, Shingo, et al.
Publicado: (2012)

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation
por: Anan, Go, et al.
Publicado: (2019)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study
por: Kubota, Yuka, et al.
Publicado: (2017)

Preoperative Butyrylcholinesterase Level as an Independent Predictor of Overall Survival in Clear Cell Renal Cell Carcinoma Patients Treated with Nephrectomy
por: Koie, Takuya, et al.
Publicado: (2014)

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
por: Hatakeyama, Shingo, et al.
Publicado: (2011)

Recent progress and perspectives on prostate cancer biomarkers
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Renal metastasis of ovarian granulosa cell tumor
por: Togashi, Kyo, et al.
Publicado: (2022)

Effect of advanced glycation end products on nocturia or sleep disorders: A longitudinal study
por: Konishi, Sakae, et al.
Publicado: (2021)

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
por: Hamaya, Tomoko, et al.
Publicado: (2021)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_r9g9m9culbvfpvtf7aajlhf209